Two Sigma Investments, LP Macrogenics Inc Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

A detailed history of Two Sigma Investments, LP transactions in Macrogenics Inc stock. As of the latest transaction made, Two Sigma Investments, LP holds 883,369 shares of MGNX stock, worth $2.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

883,369

Previous 1,223,993 27.83%

Holding current value

$2.9 Million

Previous $5.2 Million 44.13%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$3.0 - $5.55 $1.02 Million - $1.89 Million	-340,624 Reduced 27.83%	883,369 $2.91 Million
Q2 2024 Aug 14, 2024	BUY	$3.31 - $18.51 $4.01 Million - $22.4 Million	1,210,630 Added 9059.57%	1,223,993 $5.2 Million
Q1 2024 May 15, 2024	SELL	$9.77 - $21.47 $368,329 - $809,419	-37,700 Reduced 73.83%	13,363 $196,000
Q4 2023 Feb 14, 2024	SELL	$4.48 - $10.11 $6,720 - $15,165	-1,500 Reduced 2.85%	51,063 $491,000
Q3 2023 Nov 14, 2023	SELL	$4.48 - $6.19 $1.15 Million - $1.59 Million	-257,079 Reduced 83.02%	52,563 $244,000
Q2 2023 Aug 14, 2023	SELL	$4.62 - $7.54 $1.71 Million - $2.79 Million	-370,113 Reduced 54.45%	309,642 $1.66 Million
Q1 2023 May 15, 2023	SELL	$4.82 - $7.24 $104,054 - $156,297	-21,588 Reduced 3.08%	679,755 $4.87 Million
Q4 2022 Feb 14, 2023	BUY	$3.34 - $6.98 $1.03 Million - $2.15 Million	307,660 Added 78.15%	701,343 $4.71 Million
Q3 2022 Nov 14, 2022	SELL	$3.01 - $5.22 $1.8 Million - $3.13 Million	-598,884 Reduced 60.34%	393,683 $1.36 Million
Q2 2022 Aug 15, 2022	BUY	$2.25 - $9.99 $1.42 Million - $6.31 Million	631,873 Added 175.18%	992,567 $2.93 Million
Q1 2022 May 16, 2022	BUY	$8.12 - $16.9 $2.8 Million - $5.83 Million	345,046 Added 2205.05%	360,694 $3.18 Million
Q4 2021 Feb 14, 2022	BUY	$15.91 - $21.88 $248,959 - $342,378	15,648 New	15,648 $251,000
Q2 2021 Aug 16, 2021	SELL	$20.49 - $35.63 $914,366 - $1.59 Million	-44,625 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$18.99 - $33.2 $1.59 Million - $2.79 Million	-83,943 Reduced 65.29%	44,625 $1.42 Million
Q4 2020 Feb 16, 2021	SELL	$19.41 - $26.0 $682,416 - $914,108	-35,158 Reduced 21.47%	128,568 $2.94 Million
Q3 2020 Nov 16, 2020	SELL	$24.69 - $31.6 $63,601 - $81,401	-2,576 Reduced 1.55%	163,726 $4.12 Million
Q2 2020 Aug 14, 2020	BUY	$5.2 - $29.12 $432,967 - $2.42 Million	83,263 Added 100.27%	166,302 $4.64 Million
Q1 2020 May 15, 2020	SELL	$4.28 - $12.11 $210,015 - $594,225	-49,069 Reduced 37.14%	83,039 $483,000
Q4 2019 Feb 14, 2020	BUY	$7.95 - $12.27 $1.05 Million - $1.62 Million	132,108 New	132,108 $1.44 Million
Q3 2019 Nov 14, 2019	SELL	$12.44 - $17.48 $151,121 - $212,347	-12,148 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$14.51 - $19.71 $749,441 - $1.02 Million	-51,650 Reduced 80.96%	12,148 $206,000
Q1 2019 May 15, 2019	BUY	$11.11 - $25.6 $70,904 - $163,379	6,382 Added 11.12%	63,798 $1.15 Million
Q4 2018 Feb 14, 2019	BUY	$11.75 - $21.42 $674,638 - $1.23 Million	57,416 New	57,416 $729,000

Others Institutions Holding MGNX

# of Institutions

132

Shares Held

55.4M

Call Options Held

215K

Put Options Held

238K

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $202M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Macrogenics Inc Transaction History